progesterone receptor

Open Access
Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA

Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
You have access
Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis
CLARIANO PIRES DE OLIVEIRA NETO, HAISSA OLIVEIRA BRITO, RUI MIGUEL GIL DA COSTA and LUCIANE MARIA OLIVEIRA BRITO

Anticancer Research August 2021, 41 (8) 3707-3716; DOI: https://doi.org/10.21873/anticanres.15162
You have access
Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
FATEMEH NOURIEMAMZADEN, BEVERLY WORD, EBONY COTTON, ANFERNEE HAWKINS, KAI LITTLEJOHN, RHONDA MOORE, GUSTAV MIRANDA-CARBON, CHINNA NNEKA ORISH and BEVERLY LYN-COOK

Anticancer Research July 2020, 40 (7) 3669-3683; DOI: https://doi.org/10.21873/anticanres.14356
You have access
Expression of Progesterone and Androgen Receptors in the Breast of Premenopausal Women, Considering Menstrual Phase
MIA FAHLÉN, HUA ZHANG, LARS LÖFGREN, BRITT MASIRONI, EVA VON SCHOULTZ, BO VON SCHOULTZ and LENA SAHLIN

Anticancer Research March 2018, 38 (3) 1499-1510;
You have access
Increased CXCL8 Expression Is Negatively Correlated with the Overall Survival of Patients with ER-Negative Breast Cancer
QI FANG, XUFEN WANG, GUANGHUA LUO, MIAOMEI YU, XIAOYING ZHANG and NING XU

Anticancer Research September 2017, 37 (9) 4845-4852;
You have access
Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor
KLAUS BENDRAT, PETER FRITZ, SIMON MÜLLER, SYLVIA BROCKMÖLLER, ANNEGRET DEBUS, KAY FRIEDRICHS, CHRISTOPH LINDNER, FRIEDHELM BRINKMANN, ELSE HEIDEMANN and AXEL NIENDORF

Anticancer Research August 2016, 36 (8) 3855-3863;
You have access
Neural Analyses Validate and Emphasize the Role of Progesterone Receptor in Breast Cancer Progression and Prognosis
ARTURO CARONONGAN, BARBARA VENTURINI, DEBORA CANUTI, SATNAM DLAY, RAOUF N.G. NAGUIB and GAJANAN V. SHERBET

Anticancer Research April 2016, 36 (4) 1909-1915;
You have access
Histological Grade (HG) in Invasive Ductal Carcinomas of the Breast of Less than 1 cm: Clinical and Biological Associations During Progression from HG1 to HG3
ÁLVARO RUIBAL, PABLO AGUIAR, MARÍA CARMEN DEL RIO, JOSÉ IGNACIO ARIAS, PRIMITIVA MENÉNDEZ-RODRÍGUEZ, FRANCISCO GUDE and MICHEL HERRANZ

Anticancer Research January 2015, 35 (1) 569-573;
You have access
Independence of Cytotoxic Drug Sensitivity Profiles and Receptor Subtype of Invasive Ductal Breast Carcinoma Demonstrated by the Histoculture Drug Response Assay (HDRA)
KWANG YONG KIM, BONG WHA CHUNG, IK YANG, MOON BO KIM and ROBERT M. HOFFMAN

Anticancer Research December 2014, 34 (12) 7197-7201;

Main menu

User menu

Search

progesterone receptor